RNABioPrecisionSyncing biology for health
Home / Our science

Synthetic regulatory RNA

syncBASS

Designing RNA for
coordinated gene regulation.

syncBASS is RNABioPrecision’s first technology in development for designing small synthetic regulatory RNAs intended to modulate multiple genes within a biological network.

Discuss a collaboration

How syncBASS works

One designed RNA.
Several selected targets.

A designed syncBASS RNA targets selected mRNAs for downregulation. Project options include required, optional and excluded genes, absolute K_D binding affinity values in pMol, GC percentage, RNA size, and 3′UTR or CDS target regions.
Conceptual illustration of the design objective: a syncBASS RNA directed at multiple selected messenger RNAs to coordinate target gene downregulation. Projects can specify required and optional targets, genes to exclude from targeting, absolute KD values in pMol, GC%, RNA size in nucleotides, and target regions such as 3′UTR or CDS. Target labels are illustrative; the figure does not represent measured effects.

Design begins with the genes we want to downregulate. The resulting RNA is evaluated experimentally to determine the response of each selected target and the combined biological effect.

The biological problem

Genes work
in context.

A biological response can depend on the combined activity of several genes. Changing one component may leave other parts of the network unchanged.

The question behind syncBASS is whether a designed RNA can modulate a selected set of genes together to help produce a desired biological response. The design objective includes both the intended targets and the interactions we want to avoid.

The science behind the approach

From molecular recognition
to a network-level objective.

RNA regulation offers a foundation for this idea. In natural microRNA pathways, a small RNA can guide recognition of multiple messenger RNAs and influence their expression. Which targets respond depends on sequence pairing and molecular context.

01

Structure

RNA folds into structures that influence which regions are exposed and available for interactions. A sequence match alone does not fully describe a potential target.

02

Recognizability

We consider whether a target can be recognized by a regulatory RNA and its molecular partners. Sequence compatibility and structural context both inform that question.

03

Interactions

Our approach draws on RNA–RNA and RNA–protein interactions to inform design, with the aim of coordinating effects across a selected biological network.

Our design objective

Coordinate the effect.
Understand the outcome.

Coordinated regulation means designing toward a defined biological objective across several genes. It does not assume that every target changes by the same amount.

RNABioPrecision combines computational design with mechanistic knowledge of RNA structure, recognizability, and biophysical interactions. The aim is to make regulatory RNA design more precise, robust, and predictive.

Our validation work connects computational predictions to experimental measurements: which targets respond, how strongly they respond, and how their collective downregulation affects cells and biological outcomes.

Experimental validation

From target effects
to biological outcomes.

RNABioPrecision provides in vitro and in vivo validation to assess the effects of designed regulatory RNAs.

Experimental validation: measure downregulation of individual targets, assess collective effects on cells, then evaluate efficacy and toxicity in mouse studies with comparison against available inhibitors.
From target-level measurements to cellular responses and in vivo evaluation. This schematic illustrates the validation workflow, not experimental results.

In vitro validation

We measure the effect on each selected target and evaluate how their collective downregulation affects cells.

In vivo validation

In mouse studies, we measure efficacy and toxicity and compare outcomes with available inhibitors.

Potential applications

A foundation for
new biological questions.

We see potential applications in therapeutic research, agriculture, and industrial biotechnology. Each application brings its own requirements for delivery, specificity, and biological performance. Those requirements need to be evaluated in the appropriate experimental setting.

syncBASS is presented here as a technology in development. This page describes the scientific approach and its aims, rather than established clinical outcomes.

Research collaborations

What network are
you working to understand?

Discuss a collaboration